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ABSTRACT Individual mouse pancreatic islets exhibit oscillations in [Ca21]i and insulin secretion in response to glucose in vitro,
but how the oscillations of a million islets are coordinated within the human pancreas in vivo is unclear. Islet to islet synchronization
is necessary, however, for the pancreas to produce regular pulses of insulin. To determine whether neurohormone release within
the pancreas might play a role in coordinating islet activity, [Ca21]i changes in 4–6 isolated mouse islets were simultaneously
monitored before and after a transient pulse of a putative synchronizing agent. The degree of synchronicity was quantiﬁed using a
novel analytical approach that yields a parameter that we call the ‘‘Synchronization Index’’. Individual islets exhibited [Ca21]i
oscillations with periods of 3–6 min, but were not synchronized under control conditions. However, raising islet [Ca21]i with a brief
application of the cholinergic agonist carbachol (25 mM) or elevated KCl in glucose-containing saline rapidly synchronized islet
[Ca21]i oscillations for $30 min, long after the synchronizing agent was removed. In contrast, the adrenergic agonists clonidine or
norepinephrine, and the KATP channel inhibitor tolbutamide, failed to synchronize islets. Partial synchronization was observed,
however, with the KATP channel opener diazoxide. The synchronizing action of carbachol depended on the glucose concentration
used, suggesting that glucose metabolism was necessary for synchronization to occur. To understand how transiently perturbing
islet [Ca21]i produced sustained synchronization, we used a mathematical model of islet oscillations in which complex oscillatory
behavior results from the interaction between a fast electrical subsystem and a slower metabolic oscillator. Transient synchronization simulated by the model was mediated by resetting of the islet oscillators to a similar initial phase followed by transient
‘‘ringing’’ behavior, during which the model islets oscillated with a similar frequency. These results suggest that neurohormone
release from intrapancreatic neurons could help synchronize islets in situ. Defects in this coordinating mechanism could contribute
to the disrupted insulin secretion observed in Type 2 diabetes.

INTRODUCTION
Plasma insulin levels are pulsatile in many mammals, including humans (1,2), as is the secretion of insulin from the
perfused pancreas (3,4) or groups of perfused isolated islets
(2,5). The period of these oscillations varies but is generally
in the range of 5–11 min, depending on the species (6–9).
Insulin oscillations are physiologically relevant as it has been
shown that the actions of insulin on its target tissues are more
profound when the hormone is presented in a pulsatile versus
a continuous manner (10–12). Additionally, insulin pulsatility is of clinical relevance to diabetes because patients with
Type 2 diabetes and their ﬁrst-degree relatives exhibit dysregulated pulsatility (13,14).
It is known that insulin secretion is driven by oscillations in
[Ca21]i in the electrically coupled, well-synchronized network of b-cells within individual islets, and it has been recently shown that the periods of plasma insulin oscillations
measured in mice in vivo match the periods of the [Ca21]i
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oscillations of isolated mouse islets measured in vitro (15).
This is not surprising, as it is known that regulated insulin
granule exocytosis is mediated by SNARE proteins in b-cells
that require a rise in [Ca21]i for insulin granule fusion and
release to occur (16,17).
Although details of the biophysical and biochemical
mechanisms of islet [Ca21]i oscillations are being intensively
investigated, and different models have been proposed, experimental studies have made it clear that islet [Ca21]i oscillations result from an interaction between ion channels and
b-cell glucose metabolism, possibly via oscillations in both
electrical and metabolic variables. As recently reviewed (18),
these models can readily account for both the faster (e.g.,
,1 min period) and slower (e.g., 1–5 min period) types of
oscillations.
However, as the human pancreas contains ;1 million islets, the oscillatory activity of a majority of these islets must
be closely coordinated or synchronized for pulses of secretion to occur from the whole pancreas, which in turn drives
pulses of insulin (and other islet hormones) in the plasma. If
this were not the case, and individual islet oscillations were
out of phase, they would tend to cancel one another out,
resulting in a loss of pulsatility. Although there has been
progress in understanding the mechanisms that generate
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individual islet oscillations, the mechanisms involved in
mediating islet-to-islet communication and synchronization
are unknown. Thus, although it has been suggested that a
neural network operating in vivo couples the activity of diverse islets together into a functional syncytium (19,20),
there is little direct experimental evidence to support this
hypothesis, and the functional characteristics of the network
and its speciﬁc components remain unclear.
To address candidate mechanisms that may be involved
in islet-to-islet synchronization, we focused our attention on
several neurohormone systems known to reside in the pancreas in vivo that could conceivably help to synchronize islet
activity. The pancreas is innervated by cholinergic ﬁbers
(21), ample amounts of choline acetyltransferase and acetylcholinesterase are in islets (22), and M1 and M3 type muscarinic receptors are expressed on islet b-cells (23). It is well
established that parasympathetic stimulation of the pancreas
potentiates insulin secretion both before and after glucose
absorption from the gut (24), reinforcing the physiological
importance of this system in glucose homeostasis. However,
previous studies carried out in vivo using mainly pharmacological approaches to disrupt cholinergic input to the pancreas were generally unable to demonstrate a role for b-cell
muscarinic receptors in insulin plasma pulsatility (19). Although vagotomy did shift the characteristics of insulin pulsatility, this was cited as evidence for other oscillatory drivers
(25). However, besides concerns about nonspeciﬁc actions of
the drugs used as probes and other effects of vagotomy (26),
it can be difﬁcult to quantify oscillation characteristics in
vivo, which may also be subject to a variety of redundant
control mechanisms in the intact animal.
Besides cholinergic input, we also tested whether sympathetic input to the pancreas will produce synchronization, as
islets have extensive adrenergic innervation, and stimulation
of the splanchnic or mixed autonomic nerves modiﬁes islet
insulin secretion by releasing noradrenaline and inhibiting
glucose-stimulated insulin secretion by activating alpha receptors (27).
In this study, we utilized a simple experimental paradigm
that allowed us to simultaneously measure [Ca21]i oscillations
in multiple isolated mouse islets in vitro, using [Ca21]i as a
surrogate measure of insulin secretion. We note that although
oscillations in insulin secretion have been reported when
[Ca21]i is not oscillatory (28), under most conditions oscillations in [Ca21]i act as the principal driver of islet insulin oscillations (15,29–31). An advantage of this experimental
approach is that it provides information on the state of each
islet, in contrast to in vivo and perfused pancreas experiments
that only report the summed activity of all the islets.
The degree of synchronization among islets was quantiﬁed
using a novel parameter we call the Synchronization Index
(or SI; see Methods). We determined the SI before and after a
very brief application of a putative synchronizing agent.
We found that the most efﬁcacious synchronizing agent of
those tested was the cholinergic agonist carbachol, which,
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acting through M-type receptors, briskly synchronized islet
oscillatory activity and maintained synchrony for up to 30
min despite its being quickly washed out of the experimental
chamber. The ability of carbachol to synchronize islets was
glucose-dependent, as at concentrations ,7 mM glucose,
carbachol was ineffective. We also found that it was difﬁcult
to synchronize the activity of islets having divergent oscillation periods, in line with our recent proposal that the islets
of individual mice may be close in their oscillatory characteristics to facilitate such synchronization (32). It is likely that
synchronization was mediated by the perturbation of [Ca21]i
after carbachol addition, as high KCl produced a similar
degree of synchronization. In contrast, we did not observe
signiﬁcant synchronization after the application of norepinephrine or clonidine. Interestingly, the KATP opener diazoxide was partially effective in synchronizing islets.
To understand how a brief pulse of carbachol produced
sustained synchronization, we used our recent Dual Oscillator
Model (33) of islet oscillations, where oscillatory behavior is
driven by interactions between fast ion channel-mediated oscillations using [Ca21]i as a negative feedback variable, and by
a slower metabolic process, which in the present model is
oscillatory glycolysis mediated by the allosteric enzyme
phosphofructokinase-M (32,34). We performed simulations
with ﬁve model islets, which varied in oscillation period due to
heterogeneity in the value of one model parameter. Using this
model, transient synchronization was observed when [Ca21]i
was transiently elevated by the simulated application of carbachol or high KCl. The synchronization observed lasted for a
time period much longer than the duration of the pulse of
synchronizing agent. We show that the mechanism for this is
twofold. First, the [Ca21]i perturbation resets the phases of the
model islet oscillators, so that they are reset to an in-phase
state. Second, a transient ‘‘ringing’’ or damped oscillation
phase occurs during which the frequency of oscillation varies
little from islet to islet. As a result, the model islets remain in
phase, i.e., synchronized, for several minutes while the ringing
persists. The implications of these ﬁndings and their novel
theoretical basis are discussed.

MATERIALS AND METHODS
Islet preparation
Islets were isolated from the pancreata of Swiss-Webster mice using standard
collagenase digestion (35). Islets were then put into 35-mm petri dishes and
cultured in RPMI-1640 medium containing 11.1 mM glucose, fetal bovine
serum, L-glutamine, and penicillin/streptomycin (Gibco, Grand Island, NY).
Islets were kept for 1–3 days in an air/CO2 incubator at 37C.

Simultaneous measurements of [Ca21]i
oscillations in multiple islets
Islets were loaded with 5 mmol/l fura-2/AM and 0.01% pluronic acid (Invitrogen, Eugene, OR) and incubated at 37C for 30 min in an incubator.
Islets were then washed for 20 min. with a fura-2 free recording solution that
Biophysical Journal 95(10) 4676–4688
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contained (in mM): 115 NaCl, 3 CaCl2, 5 KCl, 2 MgCl2, 10 HEPES, and 11.1
mM glucose, unless the glucose sensitivity of the synchronization process
was to be determined, as stated in the text (pH 7.2). Islet [Ca21]i was measured using an inverted ﬂuorescence microscope-based (IX-50, Olympus,
Tokyo, Japan) imaging system consisting of a Xe arc excitation source, a
Ludl ﬁlter wheel (Ludl, Hawthorne, NY), and IPLab ﬂuorescence imaging
software (Scanalytics, Fairfax, VA). Using this setup, epiﬂuorescence was
simultaneously measured from 3–6 individual islets at 32–35C in a 1 ml
recording chamber continually perfused at 1 ml/min, and [Ca21]i values were
expressed as the ﬂuorescence ratio of Ca21-bound (340 nm) to Ca21-free
(380 nm) fura-2, with emission collected at 510 nm. Parallel studies using
dye-containing solutions with this system showed that complete solution
exchange within the chamber occurred within 1–2 min. Healthy islets readily
afﬁxed themselves to the glass bottom of the recording chamber, above the
fura objectives. The distance between the islets in this chamber ranged from
5 to 150 mm. A schematic of the experimental setup used is shown in Fig. 1.

Synchronization index
To quantify the degree of islet-to-islet synchronization, we developed a
measure of synchrony based on the recurrence of a calcium ﬂuorescence
trace to nearby values. This measure has been previously established for
general chaotic dynamical systems (36) and is adept at detecting synchrony
even when the traces are out of phase or nonstationary (i.e., the average value
meanders). Given that a trace T is deﬁned by its set of ﬂuorescence values
ff gN
i¼1 ; the method follows three main steps:

FIGURE 1 Schematic of experimental setup used. Small groups of islets
were placed on the bottom of a small (1 ml) experimental chamber and islet
fura-2 ﬂuorescence was collected at 510 nm after alternate excitation at 340/
380 nm. Saline was ﬂowed through the bath at 1 ml/min. (Inset) Five islets
loaded with fura-2 excited at 340 nm.
Biophysical Journal 95(10) 4676–4688
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1. Calculate the self-similarity matrix or recurrence matrix (R) for a given
e-neighborhood of trace T,


e
Ri;j ¼ H e  k fi  fj k ;

where H(x) is 1 if x . 1 and 0 otherwise.
2. Construct the generalized autocorrelation function (P) from the recurrence matrix:
Nt

+ Rei;i1t

e

P ðtÞ ¼

i¼1

Nt

:

3. Calculate the pairwise correlation function of the mean-adjusted generalized autocorrelation functions:

 ; P ðtÞ  P
 æ
ÆP1 ðtÞ  P
1
2
2
:
s 1 s2
e

SI1; 2 ¼

e

e

e

For the experiments with several islets, an average over the pairwise SIij, (i , j)
values is taken to generate the SI. We pick the tunable parameter e ¼ 0.1.

Mathematical model
We use a mathematical model to simulate the effects of bath application of
carbachol, KCl, and diazoxide. This ‘‘Dual Oscillator Model’’ has been
described in detail in Bertram et al. (33), so it will only brieﬂy be described
here. The model has three compartments: for glycolysis, mitochondrial
metabolism, and electrical activity and Ca21 handling (Fig. 2). For appropriate values of the glucokinase rate, the glycolytic compartment can produce
slow oscillations (a period of several minutes) in glycolysis, due to the action
of the allosteric enzyme phosphofructokinase (PFK). This enzyme is stimulated by its product fructose 1,6-bisphosphate (FBP) and inhibited by ATP.
It is the positive feedback of FBP that leads to oscillations, due to partial
depletion of the PFK substrate fructose 6-phosphate (37). The negative ATP
feedback onto PFK is modulatory and is not responsible for the oscillations in
the model, although it is important for synchronization.
The glycolytic compartment provides input to the mitochondrial respiration compartment. This compartment has equations for the mitochondrial

FIGURE 2 Illustration of the three compartments of the Dual Oscillator
Model (glycolytic, mitochondrial, and electrical/ionic).
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inner membrane potential, mitochondrial Ca21 concentration, mitochondrial
NADH concentration, mitochondrial ATP and ADP concentrations, and
oxygen consumption due to respiration. Mitochondrial ATP production can
be oscillatory or nonoscillatory, reﬂecting the dynamics of the glycolytic
compartment. The ATP produced by the mitochondria is transported into the
cytosol, where it has two targets, PFK and the KATP channel in the plasma
membrane. When the cytosolic ATP/ADP ratio is high, KATP channels are
deactivated, and when ATP/ADP is low the channels are activated (38).

Data analysis
Data analysis and graphics were performed using IgorPro Software
(Wavemetrics; Lake Oswego, OR) and statistical analysis was done using
GraphPad Prism (GraphPad Software, San Diego, CA). Data shown are
mean 6 SE. Where paired Student’s t-test was used to test for signiﬁcance, p
values ,0.05 were considered signiﬁcant and denoted by * in the ﬁgures;
p , 0.01 is denoted by **, and p , 0.001 are denoted by *** in all ﬁgures.

RESULTS
Individual islets displayed regular slow
oscillations in 11.1 mM glucose but were not
synchronized to one another
Previous studies have suggested that mouse islet b-cells may
synchronize with one another through a diffusible factor(s)
released by the b-cell (39–44). To test this, we ﬁrst tested
whether synchrony could be observed between islets held in
the common recording chamber and exposed to a continuous
stream of saline. Thus, islets were afﬁxed in the recording
chamber, and their [Ca21]i oscillations were recorded simultaneously, with each islet surface designated as a region
of interest in the software (Methods).
As shown in Fig. 3, in the presence of 11.1 mM glucose,
islets exhibited regular slow [Ca21]i oscillations, typically
having periods ranging from 3 to 5 min (15,32,35). From
visual inspection it is clear that the oscillations of different
islets in this case were not synchronized even after .30 min.
This was conﬁrmed by calculating the SI (see Methods) of the
traces measured under control conditions, which was 0.31 6
0.04, a relatively low value (n ¼ 19 experiments; the number
of islets tested per experiment was 4–6). Although individual

FIGURE 3 Individual islets do not synchronize in 11.1 mM glucose. An
example showing that the [Ca21]i oscillations from three different islets did not
synchronize over a period of 35 min. Representative of 10 experiments.
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islets did not synchronize under these conditions, we cannot
rule out the possibility that the moving ﬂow system we used
may have prevented us from observing coupling mediated by
diffusible factors released from the islets (see Discussion).

The cholinergic agonist carbachol synchronized
islet [Ca21]i oscillations in 11.1 mM glucose
Acetylcholine (ACh), the major parasympathetic neurotransmitter, modulates pancreatic secretion through M1 and
M3 muscarinic receptors (23,26,45,46). To test the hypothesis that b-cell muscarinic receptors could synchronize islet
oscillations, we bath applied the cholinergic agonist carbachol to islets to mimic the effects of vagal nerve stimulation.
As shown in Fig. 4 for two different groups of islets, under
control conditions islets exhibited slow or mixed fast and
slow [Ca21]i oscillations having periods of several minutes
(35). However, exposing islets to 25 mM carbachol for as
little as 15 s ﬁrst elicited a transient peak in [Ca21]i in the
islets, reﬂecting Ca21 release from a cytosolic inositol trisphosphate (IP3)-sensitive endoplasmic reticulum (ER) store
(47–50). After this peak, the [Ca21]i oscillations of the individual islets became synchronized, resulting in an increase
in the SI from a control level of 0.31 6 0.04 to 0.62 6 0.04
(p , 0.001). Fig. 4 is representative of data from 19 individual
experiments, carried out using .80 islets. We also noted that
carbachol tended to increase the periods of the [Ca21]i oscillations and increase mean [Ca21]i, consistent with the reported dual actions of ACh to release ER Ca21 and also cause
membrane depolarization (50,51). As for other potential
synchronizing agents studied, the exposure time we chose

FIGURE 4 Exogenous carbachol synchronizes islet [Ca21]i oscillations
in 11.1 mM glucose. Bath application of 25 mM carbachol for 15 s ﬁrst
initiated a peak in [Ca21]i, then synchronized the [Ca21]i signals from
different islets. Representative of 19 experiments.
Biophysical Journal 95(10) 4676–4688
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was determined empirically so that intrinsic islet oscillations
persisted. Exposing islets to certain agents for too long a time
resulted in irreversible loss of the intrinsic islet oscillations.
To conﬁrm that the actions of carbachol were mediated
by muscarinic receptors, we preexposed islets to the classic
muscarine receptor antagonist atropine (at 5 mM) for 2 min
before adding carbachol together with atropine. As can been
seen in Fig. 5, atropine prevented the synchronizing action of
carbachol (SI was 0.37 6 0.06 before, and 0.27 6 0.02 after
adding carbachol in the presence of atropine, p . 0.05; n ¼ 5)
and also blunted the early peak in [Ca21]i. This indicates that
the effect of ACh to synchronize islet [Ca21]i oscillations
was mediated by muscarinic receptors.

Glucose alone does not cause prolonged
synchronization but is required for islet
synchronization by carbachol
To test whether the concentration of glucose that islets were
exposed to was a factor in carbachol-induced islet synchronization, [Ca21]i levels were recorded from islets before and
after raising the glucose concentration from 2.8 to 11.1 mM.
As shown in Fig. 6, no oscillatory activity was seen in 2.8
mM glucose, as expected, whereas switching to saline containing 11.1 mM glucose resulted in a rise in [Ca21]i and, initially, a few well-synchronized [Ca21]i oscillations (32,35).
However, the oscillations became progressively desynchronized after the ﬁrst few cycles (representative of three experiments carried out using a total of 13 islets), consistent
with the data we observed in 11.1 mM glucose (shown in
Fig. 3 under steady-state conditions). Thus, although raising
glucose initially synchronized the islets, they quickly desynchronized over time, and glucose alone was unable to
produce the prolonged synchronization characteristic of
carbachol.
To determine how islet synchronization by carbachol depends on glucose concentration, islets were continuously

FIGURE 5 Atropine prevented the synchronizing effect of carbachol. To
test whether the synchronizing action of carbachol occurred via muscarinic
receptors, 5 mM atropine was added alone and then together with carbachol.
As shown in the ﬁgure, atropine abolished the effect of carbachol on islet
[Ca21]i synchronization.
Biophysical Journal 95(10) 4676–4688
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FIGURE 6 Individual islets desynchronize after initially synchronizing,
after glucose was increased from 2.8 to 11.1 mM.

exposed to 5.5, 7.5, 11.1, 15, or 20 mM glucose for 30 min
after loading with fura-2/AM. As shown in Fig. 7, islets
treated with saline containing 5.5 mM glucose, which is
generally subthreshold for eliciting substantial rises in
[Ca21]i and signiﬁcant insulin secretion (32,52,53) responded to carbachol stimulation with an initial coordinated
peak of [Ca21]i due to Ca21 mobilization, but then exhibited
unsynchronized oscillations. Interestingly, some of the islets
exposed to 5.5 mM glucose appeared to oscillate more
readily once carbachol was added. The degree of islet synchronization to carbachol progressively and quantitatively
increased as a function of glucose concentration, as shown in
Table 1. The results shown were representative of at least ﬁve
experiments and suggest that cholinergic-mediated islet
synchronization was glucose-dependent.
Carbachol does not synchronize [Ca21]i
oscillations in islets pre-exposed to different
glucose concentrations to alter their
oscillatory patterns
To test whether carbachol was able to synchronize islets
having different [Ca21] patterns, groups of islets were pre-

FIGURE 7 Carbachol was unable to synchronize islets exposed to 5.5
mM glucose. Islets were preincubated with 5.5 mM glucose, then challenged
with 25 mM carbachol, as shown in the ﬁgure. Carbachol potentiated [Ca21]i
oscillations, but had no effect on islet synchronization unless glucose was
sufﬁciently elevated.

Synchronization of Pancreatic Islets

4681

TABLE 1 Summary of synchronization indexes (SI) before
and after treatment with different putative synchronizing
agents. Mean 6 SE, *P \ 0.05, **P \ 0.01
Glucose
concentration
(mM)

Number of
experiments

5.5
7.5
11.1
15.0
20.0

5
7
19
7
7

SI
before
0.43
0.39
0.34
0.47
0.30

6
6
6
6
6

0.14
0.09
0.04
0.08
0.08

SI
after

P
value

6
6
6
6
6

.0.05
.0.05
,0.001
,0.01
,0.05

0.45
0.60
0.58
0.76
0.58

0.09
0.11
0.04
0.05
0.08

exposed to 7, 11.1, or 15 mM glucose for 30 min after fura-2
loading, and then transferred to the recording chamber where
they were all exposed to 11.1 mM glucose. This differential
treatment was chosen to produce a fairly wide range of oscillatory patterns (32,35). The rationale for the approach is
the well-documented action of different glucose concentrations to modify periods of mouse islet electrical or [Ca21]i
oscillations (18,31,32,54,55). The protocol used here closely
resembled the protocol shown previously (34) in which
lowering glucose from 11.1 mM for several minutes and then
adding 11.1 mM glucose back causes a maintained switch
from slow to fast oscillations. Model simulations in Bertram
et al. (34) show that such a maintained switch may be due to
bistability in the dual oscillator system, which can be slow or
fast at a given level of glucose.
As shown in Fig. 8, the islet [Ca21]i oscillations observed
during the ﬁrst 20 min before the addition of carbachol were
very diverse and were clearly not well synchronized. Thus,
some islets displayed fast, small amplitude oscillations
whereas other islets had much slower, larger amplitude

[Ca21]i oscillations. After being challenged with 25 mM
carbachol for 15 s, all islets showed an initial and relatively
prolonged [Ca21]i increase, but then generally only weak
levels of synchronization. The data shown in the inset of Fig.
8 are on an expanded timescale and reﬂect the steady-state
oscillatory behavior. These results are in accord with modeling from our own group showing that it is easier to synchronize islets having similar periods (15).
Norepinephrine and clonidine failed to
synchronize islets
Sympathetic ﬁbers of the autonomic nervous system innervate the pancreas, directly inﬂuencing endocrine function
(56,57). Many previous studies have shown that adrenergic
agonists inhibit insulin secretion in various ways, including
via inhibition of voltage-gated Ca21 channels (58), activation
of low-conductance BaCl2-sensitive K1 channels (59), and
direct inhibition of distal secretion via G-proteins coupled to
a-receptors (60,61).
To test whether adrenergic agonists inﬂuence islet synchronization, norepinephrine (NE) or the a-receptor agonist
clonidine were bath applied to islets in 11.1 mM glucose.
It was found that neither 1–100 mg/mL NE nor 10 mM clonidine was capable of synchronizing mouse islet [Ca21]i
oscillations. This was not due to their failure to act on the
a-adrenergic receptor because NE initially lowered [Ca21]i
and slowed islet [Ca21]i oscillations as expected from earlier
reports (62,63). NE application actually tended to reduce SI
from 0.35 6 0.07 to 0.26 6 0.07, although this was not
signiﬁcant (n ¼ 6, p . 0.05). For clonidine, SI decreased
from 0.40 6 0.10 to 0.36 6 0.11 after addition of the drug
(n ¼ 4, p . 0.05). The doses of these agonists used were consistent with those used in several previous reports (62,64,65).
The KATP channel opener diazoxide, which
hyperpolarizes islets also caused partial
islet-islet synchronization

FIGURE 8 Carbachol did not synchronize islets pretreated with unequal
concentrations of glucose. Islets were incubated with different glucose
concentrations (7.5, 11.1, or 15 mM) for 30 min before recording commenced, and then were exposed to saline containing 11.1 mM glucose. As
shown in the ﬁgure, the islets had different patterns of [Ca21]i oscillations.
The application of 25 mM carbachol still initiated a peak in [Ca21]i, but then
failed to synchronize islet [Ca21]i signals.

Diazoxide is a KATP channel opener that results in b-cell
hyperpolarization, a lowering of [Ca21]i, and the cessation of
glucose-stimulated insulin release (66–68). To test whether
diazoxide could cause islet synchronization, we exposed islets
to 100 mM diazoxide for 2 min in glucose-containing saline,
as shown in Fig. 9. As can be seen in the ﬁgure, the addition of
diazoxide resulted in a pronounced drop in [Ca21]i, which
lasted for .10 min, followed by a resumption of islet [Ca21]i
oscillations once the drug was washed out of the chamber.
The SI values observed before and after diazoxide exposure
were 0.33 6 0.05 and 0.59 6 0.06, respectively (n ¼ 5, p ,
0.05). These results thus suggest that hyperpolarization of the
islet membrane potential resulting from KATP channel activation can also partially synchronize islet [Ca21]i oscillations.
The slow dynamics of the action of diazoxide we observed
here may reﬂect the time required for the drug to diffuse exBiophysical Journal 95(10) 4676–4688
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FIGURE 9 Hyperpolarizing islets with diazoxide modestly increased
synchronization. Application of the KATP channel opener diazoxide to islets
for 2 min ﬁrst hyperpolarized islets, and then increased synchronization.

tensively enough through the islet to open a sufﬁciently large
number of KATP channels to repolarize the islet.

Depolarizing islets with high KCl but not
tolbutamide also enhanced islet
[Ca21]i synchronization
21

As carbachol increases [Ca ]i in islets, we tested whether
other ways to increase islet [Ca21]i might also synchronize
islet [Ca21]i oscillations. We thus exposed islets to 30 mM
KCl for 30 s or to 100 mM tolbutamide for 2 min to test
whether these agents, which provoke Ca21 inﬂux through
b-cell Ca channels (55,69,70), were also capable of synchronizing islet oscillations. As shown in Fig. 10, KCl was able to
synchronize islets, with the SI before and after KCl addition
being 0.34 6 0.04 and 0.63 6 0.05, respectively (n ¼ 10, p ,
0.01). In contrast, the addition of tolbutamide did not lead to
synchronization (data not shown) and the SI actually decreased from 0.46 6 0.13 to 0.37 6 0.13(n ¼ 4, p . 0.05).
These results suggest that Ca21 inﬂux produced by high KCl
caused [Ca21]i synchronization. Fig. 11 compares SI values
for all putative synchronizing agents tested in this study.

FIGURE 10 Depolarizing islets with 30 mM KCl successfully synchronized islets.
Biophysical Journal 95(10) 4676–4688

FIGURE 11 Summary of SI before and after treatment for all groups.
SI was used to compare the efﬁcacy of carbachol and other agents to synchronize islet [Ca21]i oscillations. As shown in the ﬁgure, carbachol, diazoxide,
and KCl were able to signiﬁcantly synchronize islet [Ca21]i oscillations.
Open circles represent SI before treatments, solid circles represent SI
after treatments. (*), (**), and (***) indicate p , 0.05, 0.01, and 0.001,
respectively, versus before treatments. N represents the number of replicates.

Model simulations suggest a mechanism to
account for synchronization
We use the Dual Oscillator Model (33) to understand the
mechanism through which brief application of carbachol,
KCl, or diazoxide can synchronize islet Ca21 oscillations.
The model is capable of producing a range of oscillatory
patterns, including fast bursting (period ;15 s), slow bursting (period ;5 min), and compound bursting (fast bursts
grouped into slower episodes). In the case of fast bursting, the
glycolytic component of the model is nonoscillatory, and fast
bursting oscillations are due to Ca21 feedback onto Ca21activated K1 channels. However, glycolysis may be oscillatory, leading to slow oscillations in metabolism that have,
as one target, the KATP channels. In this case, either slow or
compound bursting is produced. The glycolytic compartment
may be endogenously oscillatory, even if the plasma membrane potential is clamped (34). Alternatively, if the parameter values are modiﬁed, the glycolytic compartment may
only be oscillatory when there are bursting electrical oscillations. In this case, clamping the membrane potential can
terminate metabolic oscillations (18). For clarity, we refer to
the ﬁrst scenario, where the glycolytic compartment produces
endogenous oscillations, as burst-independent glycolytic
oscillations. We refer to the second scenario, where oscillations in glycolysis only occur in the presence of electrical
bursting, as burst-dependent glycolytic oscillations.
Fig. 12 A shows two episodes of compound Ca21 oscillations, with oscillations in the glycolytic intermediary FBP
superimposed. This is an example of burst-dependent glycolytic oscillations. The oscillating FBP reﬂects oscillations
in glycolysis, which acts through mitochondrial respiration to
ultimately produce oscillations in the cytosolic ATP/ADP
ratio. This ratio regulates the activity of KATP channels so that
the number of open KATP channels is reduced when the ratio
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FIGURE 12 (A) Two compound oscillations in cytosolic Ca21 concentration (in mM). The FBP time course is superimposed and scaled to
facilitate comparison with Cac. (B) Cytosolic Ca21, ATP concentrations, and
PFK reaction rate before, during, and after a 30 s pulse of IP3 from 0 to 0.3
mM. Both ATP and the PFK rate have been scaled.

is elevated (38). In this way, slow oscillations in glycolysis
cause slow oscillations in the hyperpolarizing KATP current,
which groups bursts of electrical activity into episodes, as
shown in Fig. 12 A.
The oscillations in glycolysis are due to PFK, which is
activated by its product FBP (71,72). Oscillations in the PFK
reaction rate lead to oscillations in the glycolytic intermediates, including FBP, and ultimately to oscillations in mitochondrial ATP production. Fig. 12 B shows the effect of a
simulated pulse of IP3 on the PFK reaction rate, and the cytosolic Ca21 and ATP concentrations. A 30 s pulse of IP3 is
used to simulate the bath application of carbachol, since
carbachol leads to cytosolic IP3 production. When IP3 is
applied in the model, the cytosolic Ca21 concentration (Cac)
immediately increases, due to release of Ca21 from the ER.
This Ca21 must be pumped out of the cytosol, into the ER
through Sarco-Endoplasmic Reticulum Ca21 ATPases
(SERCA pumps), or out of the cell through Ca21 ATPases in
the plasma membrane (PMCA pumps). Both types of pump
hydrolyze ATP to perform the pumping, reducing the cytosolic ATP concentration. This is evident in Fig. 12 B, when
Cac (black curve) rises during the IP3 pulse whereas the cytosolic ATP concentration (ATPc, green curve) declines.
ATP is an inhibitor of PFK (73), so when ATPc declines, the
PFK will be disinhibited. This results in a spike in the PFK
activity rate (red curve). In this way, the pulse of IP3 due to a
brief application of carbachol leads to a perturbation of the
activity rate of PFK, and thus a perturbation in the time
course of the glycolytic oscillator.
Fig. 13 A shows the time courses of Cac for ﬁve model
islets, shown before and after an IP3 pulse. The ﬁve traces are
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FIGURE 13 (A) Model simulation showing the Ca21 time courses of ﬁve
different islets, before and after a 30 s IP3 pulse. Traces have been stacked to
improve visibility. The islets differ from one another in the glucokinase
reaction rate (the JGK parameter). The model islets start with identical initial
conditions, but drift apart since they have different intrinsic periods. The IP3
pulse synchronizes them, although they have drifted apart again by the end
of the simulation. (B) The FBP time courses of the ﬁve model islets are
clearly out of phase before the IP3 pulse. This pulse results in a spike of FBP,
after which the FBP time courses are synchronized while the glycolytic
oscillators are ringing (producing large amplitude FBP oscillations). As the
oscillators return to their regular periodic motion, they desynchronize.

stacked to improve visibility. The model islets differ in a
single parameter, JGK, which is the glucokinase reaction rate.
Because of differences in the value of this parameter, the
islets have different oscillation periods. At the beginning of
the simulation, all islets start from the same initial conditions,
so they are initially synchronized. As time progresses, however, the islet oscillations drift apart due to their different
periods. At 50 min after the start of the simulation, a 30 s IP3
pulse is applied (IP3 increased from 0 to 0.3 mM). This causes
the expected spike in Cac in all islets. After the spike, the
islets are synchronized, and remain synchronized for ;20
min before beginning to drift apart. By the end of the simulation, the islets have mostly desynchronized.
The mechanism for the IP3-induced synchronization is
more evident in Fig. 13 B, which shows the time course of the
glycolytic variable FBP for each of the ﬁve islets. Although
the model islets all start together, the FBP oscillations for the
different islets quickly drift apart. As expected from Fig. 12
B, the IP3 pulse causes a surge in FBP in all islets. The FBP
surge resets the model oscillators to nearly the same phase,
putting them all into an in-phase state. After this surge, the
FBP concentrations for the model islets are largely synchronized with large amplitude. However, this is only transient behavior, as the FBP time courses for the different islets
slowly drift apart, and the amplitudes for most islets decrease
to much smaller values. That is, there is a transient ‘‘ringing’’
in the glycolytic oscillators after they are perturbed by the IP3
Biophysical Journal 95(10) 4676–4688
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pulse. This ringing reﬂects a transient phase of burst-independent glycolytic oscillations. During the ringing, the model
islets oscillate with approximately the same frequency, since
the frequency of bursting-independent glycolytic oscillations
is relatively insensitive to parameter variations. Since the IP3
pulse resets the oscillators to the in-phase state, and since they
oscillate with the same frequency while the ringing persists,
the FBP and Cac time courses are transiently synchronized
among the model islet population. However, once the ringing
ends and burst-independent glycolytic oscillations are replaced by burst-dependent glycolytic oscillations, the system
returns to its regular periodic motion, and the FBP and Cac
time courses for the different islets drift apart, just as they did
at the beginning of the simulation.
Another view of the ringing of the glycolytic oscillator
is shown in Fig. 14. This shows Cac, ATPc, and the PFK
reaction rate before and after the IP3 pulse. There is a clear
spike in PFK during the pulse, followed by four large-amplitude ringing oscillations in PFK that persists for ;10 min.
This causes large downward spikes in the ATP concentration
(when the PFK is at the bottom of an oscillation), which set
the phase of the compound electrical and Ca21 oscillations
(a compound oscillation begins after each downward ATP
spike). Although this ﬁgure shows only one of the ﬁve model
islets, similar ringing occurs in each islet. In summary, the
trigger for the synchronization is the IP3-induced perturbation in the cytosolic Ca21 concentration, which affects the
glycolytic oscillator through ATP consumption, as illustrated
in Fig. 12 B. The synchronization continues only during the
transient ringing in the glycolytic oscillators (Figs. 13 B and 14).
When the brief application of KCl is simulated by transiently increasing the K1 Nernst potential, the result is similar to an IP3 pulse (simulation not shown). That is, the KCl
causes an increase in Cac (this time due to depolarization and
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Ca21 entry through L-type channels), which as before results
in a lowering of the cytosolic ATP level due to extra ATP
consumption, and a subsequent increase in the PFK reaction
rate. Except for the membrane depolarization, the effect of a
KCl pulse is similar to Fig. 13 B. Thus, as expected, a KCl
pulse of sufﬁcient size perturbs the PFK activity resulting in
transient ringing, during which the model islets are synchronized. Smaller KCl pulses, which raise Ca21 to a lesser
extent, are less effective at synchronizing the model islets.
Simulated application of diazoxide works in a somewhat
different way to synchronize the model islets (simulation not
shown). This maneuver, simulated by setting the fraction
of open KATP channels to 1, causes hyperpolarization of the
model islet. This lowers Cac, causing ATPc to increase, since
its consumption by pumps is reduced. The end result is a
transient reduction in PFK activity, which disturbs the glycolytic oscillator. Once the diazoxide is removed, the perturbation in PFK activity results in transient ringing, and
while this continues the model islets are synchronized. In the
simulations, the perturbation in PFK induced by hyperpolarizing the islets with diazoxide is not as great as the perturbation caused by increasing the Ca21 concentration with an
IP3 pulse or KCl, so the ringing and accompanying islet synchronization do not last as long.

DISCUSSION
Individual islet oscillations can be synchronized
by ACh
Individual b-cells within islets of Langerhans are synchronized through gap junctions (74–77), resulting in uniform
electrical bursting, [Ca21]i oscillations and pulsatile insulin
secretion (35,54,78,79). However, how these electrical and

FIGURE 14 A 30 s IP3 pulse induces a large spike in PFK activity, followed for 10 min by large-amplitude ringing, in a single model islet. This results in large
downward spikes in the cytosolic ATP concentration, which sets the phase of the compound electrical and Ca21 oscillations. While the PFK activity is ringing, the
model islets are synchronized.
Biophysical Journal 95(10) 4676–4688
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[Ca21]i signals are coordinated between islets in vivo to
produce pulses of insulin in plasma is poorly understood.
It is known that parasympathetic and sympathetic nervous
input to the pancreas play an important role in controlling
insulin secretion and blood ﬂow in islets (27,80,81), but the
possible role of neurohormones in islet synchronization is
unclear. Earlier studies conducted in vivo in canines and
humans were done using either vagotomy or muscarinic receptor antagonist or agonists to alter cholinergic function.
Although most of these early studies failed to convincingly
demonstrate changes in pulsatility using these approaches
(19,25), a shift in period was seen with vagotomy. Other
studies have emphasized the importance of the nervous system for insulin secretion as the Na1 channel blocker TTX
disrupted pulses of insulin in plasma when applied in vivo
(19) and cholinergic agonists (82) and nicotinic antagonists
(83) were effective as well. However, the interpretation of in
vivo studies using pharmacologic approaches is complicated
by actions of drugs on autonomic ganglia as well as b-cells
and other targets (26). Of course, there may also be species
differences in the mechanisms of synchronization of islet-toislet oscillations within the pancreas (27).
To address the issue of islet-to-islet synchronization using
a simpliﬁed in vitro approach, we used the [Ca21]i indicator
fura-2 to monitor changes in islet [Ca21]i in groups of isolated islets exposed to various agents in real time. As shown
in this article, carbachol was in fact capable of synchronizing
islet [Ca21]i, whereas the adrenergic agonists NE and clonidine were not. In addition, this ability of carbachol depended
on glucose concentration and presumably its metabolism.
Possible mechanisms involved in
synchronization in vitro
It has long been known that ACh potentiates insulin release
from islets by mobilizing Ca21 from IP3-sensitive stores (26),
depolarizing b-cells by increasing their cationic conductance
(51,84,85), and by increasing phospholipase C activation (86,
87). Our results suggest that in addition, carbachol can have
a synchronizing action on islets. The synchronizing effect of
carbachol was mediated by muscarinic receptors because it was
abolished by atropine, consistent with previous reports that
the M1 and M3 subtypes of the muscarinic receptor are expressed on b-cells and are important functionally (26,45,88).
Our ﬁnding that the action of carbachol to synchronize islets
was glucose dependent could reﬂect the well-known glucose
dependence of acetylcholine action on beta cells (50) and/or the
fact that low glucose concentrations produced weaker Ca oscillations on their own. At present we have no data to separate
these possibilities.
We also tested whether KCl or tolbutamide, which both
depolarize b-cells and raise [Ca21]i, were similarly able to
synchronize islets. We found that KCl was able to increase SI
signiﬁcantly (Fig. 10). Tolbutamide was generally unable to
synchronize islets. We are unable to explain why KCl and
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tolbutamide differed in their ability to synchronize islets. On
the other hand, hyperpolarization of the islets with diazoxide
did enhance islet synchronization (Fig. 9).
How does a rise in cytosolic Ca21
synchronize islets?
A striking feature of the experimental observations is that
even transiently perturbing islet [Ca21]i is able to produce
sustained synchronization of islet [Ca21]i oscillations, which
we presume are fundamentally metabolic in origin. As a ﬁrst
step toward understanding how this might work, we used our
Dual Oscillator Model ((33), Fig. 2) to carry out simulations
of the experiments carried out here.
In the Dual Oscillator Model, the transient synchronization
we observed experimentally was readily simulated by perturbing islet [Ca21]i to an extent that lowered ATP/ADP,
resulting in the slow ‘‘ringing’’ of b-cell PFK activity, the
source of the slow metabolic oscillations in this model. This
ringing reﬂects a transient phase of burst-independent glycolytic oscillations, which are larger in amplitude than the
burst-dependent oscillations. These oscillations are only
modestly modulated by electrical bursting, unlike the burstdependent glycolytic oscillations that require electrical
bursting. The frequency of burst-independent oscillations is
relatively insensitive to variations in parameter values that
produce islet heterogeneity. Thus, during ringing, all model
islets oscillate at almost the same frequency. The [Ca21]i
perturbation also resets the model islets to an initial in-phase
state. Therefore, while the ringing persists, the model islets
remain in phase. Once the ringing stops, the model islets
return to their original burst-dependent glycolytic oscillations
and become desynchronized once again.
Interestingly, in the model simulations shown, the oscillations speed up during the ringing phase, immediately after
the synchronizing phase. However, this was not observed in
the experimental data. Although the reasons for this apparent
discrepancy are not yet clear, using different parameter
values, synchronization can be simulated using the model
without this speeding up in period (data not shown). However, in these simulations, the islets desynchronize more
quickly than in Fig. 13.
Physiological implications
These results suggest that acetylcholine release from intrapancreatic neurons within the pancreas may help synchronize
islets in situ to mediate pulsatile pancreatic insulin secretion
via a novel mechanism involving the dynamics of a metabolic oscillator intrinsic to islets. It is enticing to speculate
that the release of ACh in the intact pancreas due to the activity of vagal neurons may provide sufﬁcient stimulation of
b-cell muscarine receptors to enable the synchronization of
islet-to-islet oscillatory activity, even without ACh release
itself being pulsatile. However, as discussed earlier, these
Biophysical Journal 95(10) 4676–4688
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results differ from those observed in vivo in humans (25) and in
dog (19,82). Whether this reﬂects differences between the
species under study, problems with the earlier studies, or the
possibility that islet synchronization is a multiparameter redundant system remains to be established. Recent progress
in carrying out glucose clamp studies and measurements
of plasma insulin oscillations in mice suggests new in vivo
studies might be feasible to directly address this (15,89).
An alternative to ACh as a synchronizing agent is ATP
released from peptidergic, intrapancreatic neurons, as well as
b-cells themselves. It has previously been reported that nitric
oxide and ATP can synchronize isolated b-cells (40,41),
which suggests that diffusible factors released by b-cells
might synchronize islets. We note that others have failed to
ﬁnd this effect, however (90).
Nonetheless, a study by Salehi et al. (91) showed that
pulsatility in the perfused rat pancreas was eliminated by the
blockade of P2Y receptors using 2-deoxy-N-methyladenosine3,5-bisphate (MRS 2179). Since MRS 2179 did not abolish
oscillations in rat b-cell aggregates, in which gap junctional
coupling presumably was able to maintain synchronization,
it was concluded that the effect of purinergic blockade was
speciﬁc to disrupt synchrony rather than the pulsatility of
b-cells per se. However, as the drug showed an effect to
depolarize both single b-cells and aggregates and the mean
insulin release increased, it is difﬁcult to rule out a primary
effect to inhibit the pulsatility of the islets in the intact
pancreas by depolarization beyond the oscillatory range.
Nonetheless, this is an attractive alternative hypothesis to
explore. Use of the in vitro preparation described here may
be of value in separating effects on synchrony from effects
on intrinsic pulsatility of islets. In limited experiments we
did not observe effects of ATP to synchronize islets in vitro
(L. Satin and M. Zhang, unpublished data), but further work
in this direction is needed to reach a clear conclusion.
Defects in the coordinating mechanism could contribute to
the disrupted insulin secretion characteristic of Type 2 diabetic patients. It is also intriguing to speculate that the synchronization of islet oscillations by diazoxide may contribute to the
recently reported actions of diazoxide administration to increase
glucose-induced insulin secretion in diabetics by mediating a
period of ‘‘b-cell rest’’ (92). We were able to show that the
synchronizing actions of diazoxide were also simulated by the
model because even a drastic lowering of islet [Ca21]i resulted
in the slow ringing of PFK activity after its pronounced drop via
increased ATP/ADP.
In summary, we have demonstrated that cholinergic
stimulation can synchronize a small group of mouse islets
in vitro. In contrast, sympathetic agonists such as NE or the
a2-adrenoceptor agonist clonidine lacked this ability. The
effects of carbachol may involve ER Ca21 release as well as
Ca21 inﬂux. The results could be accounted for by a mathematical model where the slow dynamics of mouse islets and
the regulation of the oscillatory processes by Ca21 led to
slow damped oscillations during which islet Ca21 cycles
Biophysical Journal 95(10) 4676–4688
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were in phase. We thus suggest that neurohormones released within the pancreas may in turn help synchronize
islets by periodically pacing distant islets by detuning the
slow oscillatory processes that are intrinsic to each islet.
Speciﬁcally, parasympathetic nerve input to the pancreas,
by periodically releasing ACh onto b-cells, might contribute
to islet-to-islet communication and therefore help maintain
the coordinated activity of the system. If this was the case,
it would be interesting to test whether insulin pulsatility is
modiﬁed in islets from M3-receptor knockout mice, or after
vagotomy.
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